Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7086008 | 0.82 | HTT (0.54) | MAPTALDH1A1MEN1KMT2ATDP1 | |
| SCHEMBL3908874 | 0.81 | ALDH1A1 (0.52) | MAPTALDH1A1KMT2ATDP1POLB | |
| SCHEMBL111190 | 0.76 | MAPT (0.50) | ADRB2FFAR4MAPTALDH1A1MEN1 | |
| SCHEMBL209875 | 0.76 | TSHR (0.51) | ADRB2FFAR4MAPTALDH1A1MEN1 | |
| SCHEMBL8608887 | 0.72 | KMT2A (0.53) | FFAR4MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL11141519 | 0.71 | MEN1 (0.55) | FFAR4MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL3859488 | 0.71 | ALDH1A1 (0.54) | MAPTALDH1A1MEN1KMT2APOLB | |
| SCHEMBL8318543 | 0.71 | EGFR (0.48) | MAPTALDH1A1MEN1KMT2APOLB | |
| SCHEMBL8641030 | 0.71 | HCAR3 (0.49) | MAPTALDH1A1TDP1POLBSMN1; SMN2 | |
| SCHEMBL8799847 | 0.71 | ALDH1A1 (0.50) | MAPTALDH1A1KMT2ATDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003099242-A1 | COSMETIC AGENTS CONTAINING PROTEIN DISULFIDE ISOMERASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-12-04 | — | — | WO | claimed |
| US-8992633-B2 | Disulfide dyes | BASF SE (DE) | 2015-03-31 | — | — | US | disclosed |
| US-20140157529-A1 | DISULFIDE DYES | BASF SE (DE) | 2014-06-12 | — | — | US | disclosed |
| US-20080295260-A1 | Disulfide Dyes, Composition Comprising them and Method of Dyeing Hair | CIBA SPECIALTY CHEMICALS CORP. | 2008-12-04 | — | — | US | disclosed |
| WO-2003099243-A1 | COSMETIC AGENTS CONTAINING PROTEIN DISULFIDE ISOMERASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-12-04 | — | — | WO | disclosed |
| WO-2003099242-A1 | COSMETIC AGENTS CONTAINING PROTEIN DISULFIDE ISOMERASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080295260-A1 | Disulfide Dyes, Composition Comprising them and Method of Dyeing Hair | STS, CYP2S1, SQOR | ADRB2 2349/4885FFAR4 4447/4885MAPT 4591/4885 |
| US-20140157529-A1 | DISULFIDE DYES | KRT18, COL1A1, SULT1A1 | ADRB2 3827/4885FFAR4 4782/4885MAPT 1432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.